Developer docs
API playgroundTry for free, no card

Search company profiles

Citron Research

Full company profile

uuid0005iv2

Namestring
Citron Research
Legal namestring
Citron Research
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Citron Research is a private, founder-operated financial research firm founded in 2001 by Andrew Left and based in California, USA. The company publishes investment commentary and short-selling research on publicly traded companies, distributing over 150 reports since inception through its website citronresearch.com and via earned media on CNBC and Fox Business. Citron's core product is its stock commentary reports, which identify companies it believes are overvalued, engaged in fraudulent activity, or operating terminal business models; the firm and its principals may hold long or short positions in the securities profiled, making the primary economic engine the gains from those trading positions rather than a subscription or licensing fee for the research itself. The company does not operate a paid product, subscription tier, or enterprise sales channel; all research is freely accessible, and the audience consists of retail and professional investors who self-serve content from the website or encounter it through Andrew Left's television appearances. Underlying technology is minimal — the platform is a content publishing site with no proprietary software infrastructure; the firm's real asset is the editorial judgment of its investigators and a 24-year track record in which more than 50 covered companies have subsequently faced SEC charges, DOJ charges, or delistings. The business is heavily centralized around Andrew Left as Founder and Executive Editor, with no disclosed headcount, no funding rounds, no institutional investors, and no disclosed revenue.

Short descriptiontext

Citron Research is a private, founder-operated financial research firm founded in 2001 by Andrew Left, publishing free short-selling reports and stock commentary on publicly traded companies to retail and professional investors via its website and media appearances.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
stock research reports, short selling research, equity research, investment commentary, financial analysis
Industry1 code
PRIMARYFSACAGAA
Equity Research
Financial & Insurance/Capital Markets & Securities/Securities Research & Analytics
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Equity Research & Stock Commentary
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Short-Selling Research and Market Commentary
TypeAdvertising
Description

Citron Research generates returns through short-selling positions in publicly traded companies. The firm's research reports identify companies they believe are overvalued or engaged in fraudulent activities. Andrew Left and associated Citron Related Persons hold positions (long or short) in securities profiled on the site, and may realize significant gains when stock prices decline following publication of their research. This is the primary economic model—research drives market attention and position gains.

citronresearch.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Technology or R&D, Operations
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Citron Research publishes stock commentary and short-selling research reports on publicly traded companies through its website citronresearch.com, led by founder Andrew Left. Reports are distributed free of charge as PDF reports and web content, and the firm and its associated principals hold long or short positions in the securities profiled to capture gains when market views move. The offering is a single-product financial research service with over 150 reports published since 2001.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 50+ companies covered have subsequently faced regulatory interventions
+1 more record
Product overview1 text field

Citron Research is a single-product financial research service focused on stock commentary and investment analysis. The company publishes research reports on publicly traded securities, led by founder Andrew Left. The offering consists of stock analysis reports delivered through the Citron Research website, with over 150 reports published since 2001. The service operates as a subscription-free platform where reports are freely accessible, with the company and its principals holding positions in the securities profiled.

Product and service1 record
1Citron Research Stock Commentary Reports
CategoryEquity Research / Stock Commentary
Description

Published stock research reports providing analysis and commentary on publicly traded securities, identifying investment opportunities and risks, with a particular focus on short-selling ideas, fraud identification, and terminal business models. Reports are delivered free of charge to retail and professional investors via citronresearch.com as PDF reports and web content, and the firm and its associated persons hold positions in the securities profiled.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large-scale equity research and investing commentary platform with a wide contributor base publishing both long and short theses. Broader incumbent to Citron: overlaps in equity commentary distribution but operates at vastly greater scale, with subscription monetization and a marketplace model rather than a single founder-led short-research voice.

2Hindenburg Research
TypeDirect peer
Description

Independent forensic research firm known for publishing high-profile short reports alleging fraud and structural business issues at public companies. Closely mirrors Citron's model of free, public, founder-published short theses.

3Viceroy Research
TypeDirect peer
Description

Short-focused research firm publishing exposés on publicly listed companies, often with a forensic/financial-fraud orientation. Operates in the same niche as Citron — publicly distributed, thesis-driven short research.

4Bonitas Research
TypeDirect peer
Description

Activist short-focused research firm publishing reports alleging fraud, accounting irregularities, or terminal business models at public companies. Closely comparable to Citron in scope and audience.

TypeDirect peer
Description

Activist investment manager that publicly publishes both long and short investment theses with detailed research reports. Comparable to Citron in founder-driven public short research targeting overvalued or allegedly fraudulent issuers.

6Iceberg Research
TypeDirect peer
Description

Independent research firm publishing short-selling reports on companies suspected of fraud or accounting manipulation. Directly comparable to Citron in publication format, free distribution, and short-only thesis style.

TypeDirect peer
Description

Activist short-selling research firm that publishes short reports on public companies alleged to be engaged in fraud. Operates in the same direct-distribution, founder-led short-research format as Citron.

8Spruce Point Capital Management
TypeDirect peer
Description

Activist short seller that publishes detailed research reports challenging the business and accounting practices of public companies. Comparable to Citron in publicly distributed, founder-driven short theses.

TypeDirect peer
Description

Activist short-selling research firm founded by Carson Block, publishing forensic short reports on publicly traded companies. Directly comparable to Citron in thesis-driven, public-distribution short research with founder-led publishing.

10Glasshouse Research
TypeDirect peer
Description

Independent short-selling research firm publishing forensic short reports on listed companies. Direct peer to Citron in free, public, founder-published activist short research.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Citron Research

Equity Research & Stock Commentarycitronresearch.com

Citron Research is a private, founder-operated financial research firm founded in 2001 by Andrew Left, publishing free short-selling reports and stock commentary on publicly traded companies to retail and professional investors via its website and media appearances.

What Citron Research does

Citron Research is a private, founder-operated financial research firm founded in 2001 by Andrew Left and based in California, USA. The company publishes investment commentary and short-selling research on publicly traded companies, distributing over 150 reports since inception through its website citronresearch.com and via earned media on CNBC and Fox Business. Citron's core product is its stock commentary reports, which identify companies it believes are overvalued, engaged in fraudulent activity, or operating terminal business models; the firm and its principals may hold long or short positions in the securities profiled, making the primary economic engine the gains from those trading positions rather than a subscription or licensing fee for the research itself. The company does not operate a paid product, subscription tier, or enterprise sales channel; all research is freely accessible, and the audience consists of retail and professional investors who self-serve content from the website or encounter it through Andrew Left's television appearances. Underlying technology is minimal — the platform is a content publishing site with no proprietary software infrastructure; the firm's real asset is the editorial judgment of its investigators and a 24-year track record in which more than 50 covered companies have subsequently faced SEC charges, DOJ charges, or delistings. The business is heavily centralized around Andrew Left as Founder and Executive Editor, with no disclosed headcount, no funding rounds, no institutional investors, and no disclosed revenue.

Citron Research firmographics

Firmographics
Name
Citron Research
Legal name
Citron Research
Website
https://citronresearch.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
1–10 employees
Short description
Citron Research is a private, founder-operated financial research firm founded in 2001 by Andrew Left, publishing free short-selling reports and stock commentary on publicly traded companies to retail and professional investors via its website and media appearances.
Ownership category
akta.pro rank

Citron Research industry classification

Industry
Product category
Equity Research & Stock Commentary
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSACAGAA
Equity Research
Financial & Insurance/Capital Markets & Securities/Securities Research & Analytics

Keywords

  • Stock research reports
  • Short selling research
  • Equity research
  • Investment commentary
  • Financial analysis

Where Citron Research is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Markets served

Citron Research business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Short-Selling Research and Market Commentary: Citron Research generates returns through short-selling positions in publicly traded companies. The firm's research reports identify companies they believe are overvalued or engaged in fraudulent activities. Andrew Left and associated Citron Related Persons hold positions (long or short) in securities profiled on the site, and may realize significant gains when stock prices decline following publication of their research. This is the primary economic model—research drives market attention and position gains.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Citron Research product offering

Product offering

Core offering

Citron Research publishes stock commentary and short-selling research reports on publicly traded companies through its website citronresearch.com, led by founder Andrew Left. Reports are distributed free of charge as PDF reports and web content, and the firm and its associated principals hold long or short positions in the securities profiled to capture gains when market views move. The offering is a single-product financial research service with over 150 reports published since 2001.

Product overview

Citron Research is a single-product financial research service focused on stock commentary and investment analysis. The company publishes research reports on publicly traded securities, led by founder Andrew Left. The offering consists of stock analysis reports delivered through the Citron Research website, with over 150 reports published since 2001. The service operates as a subscription-free platform where reports are freely accessible, with the company and its principals holding positions in the securities profiled.

Differentiator

Problem solved

Functional benefit

Products and services

  • Citron Research Stock Commentary Reports Published stock research reports providing analysis and commentary on publicly traded securities, identifying investment opportunities and risks, with a particular focus on short-selling ideas, fraud identification, and terminal business models. Reports are delivered free of charge to retail and professional investors via citronresearch.com as PDF reports and web content, and the firm and its associated persons hold positions in the securities profiled.

Quantifiable outcome

  • 50+ companies covered have subsequently faced regulatory interventions
  • +1 more outcomes

Companies that use Citron Research

Customer profile

Segments1 record

Ideal customer profiles1 record

Citron Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Citron Research partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Citron Research competitors and assessment

Company assessment

Broad incumbents

  • Seeking Alpha: Large-scale equity research and investing commentary platform with a wide contributor base publishing both long and short theses. Broader incumbent to Citron: overlaps in equity commentary distribution but operates at vastly greater scale, with subscription monetization and a marketplace model rather than a single founder-led short-research voice.

Direct peers

  • Hindenburg Research: Independent forensic research firm known for publishing high-profile short reports alleging fraud and structural business issues at public companies. Closely mirrors Citron's model of free, public, founder-published short theses.
  • Viceroy Research: Short-focused research firm publishing exposés on publicly listed companies, often with a forensic/financial-fraud orientation. Operates in the same niche as Citron — publicly distributed, thesis-driven short research.
  • Bonitas Research: Activist short-focused research firm publishing reports alleging fraud, accounting irregularities, or terminal business models at public companies. Closely comparable to Citron in scope and audience.
  • Kerrisdale Capital: Activist investment manager that publicly publishes both long and short investment theses with detailed research reports. Comparable to Citron in founder-driven public short research targeting overvalued or allegedly fraudulent issuers.
  • Iceberg Research: Independent research firm publishing short-selling reports on companies suspected of fraud or accounting manipulation. Directly comparable to Citron in publication format, free distribution, and short-only thesis style.
  • Wolfpack Research: Activist short-selling research firm that publishes short reports on public companies alleged to be engaged in fraud. Operates in the same direct-distribution, founder-led short-research format as Citron.
  • Spruce Point Capital Management: Activist short seller that publishes detailed research reports challenging the business and accounting practices of public companies. Comparable to Citron in publicly distributed, founder-driven short theses.
  • Muddy Waters Research: Activist short-selling research firm founded by Carson Block, publishing forensic short reports on publicly traded companies. Directly comparable to Citron in thesis-driven, public-distribution short research with founder-led publishing.
  • Glasshouse Research: Independent short-selling research firm publishing forensic short reports on listed companies. Direct peer to Citron in free, public, founder-published activist short research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Citron Research social profiles

Digital presence

Citron Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Citron Research leadership team

Management profile

Number of profiles

Profiles1 record

Citron Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Citron Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Citron Research

What does Citron Research do?

Citron Research publishes stock commentary and short-selling research reports on publicly traded companies through its website citronresearch.com, led by founder Andrew Left. Reports are distributed free of charge as PDF reports and web content, and the firm and its associated principals hold long or short positions in the securities profiled to capture gains when market views move. The offering is a single-product financial research service with over 150 reports published since 2001.

Is Citron Research a public or private company?

Citron Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Citron Research founded?

Citron Research was founded in 2001. It employs 1 to 10 people.

Where is Citron Research based?

Citron Research is headquartered in Los Angeles, United States, in the North America region.

How does Citron Research make money?

One revenue line is on record: short-Selling Research and Market Commentary.

Who are Citron Research's main competitors?

Seeking Alpha is listed as a broad incumbent. Direct peers are Hindenburg Research, Viceroy Research, Bonitas Research, Kerrisdale Capital, Iceberg Research, Wolfpack Research, Spruce Point Capital Management, Muddy Waters Research and Glasshouse Research.

Does Citron Research have an API?

No public API is recorded for Citron Research.

What industry is Citron Research in?

Citron Research's product category is Equity Research & Stock Commentary. Its primary akta.pro industry code is FSACAGAA, Equity Research. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanIGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short CampaignIGC Pharma announced it is evaluating potential civil remedies following a federal jury verdict finding Andrew Left, founder of Citron Research, guilty of securities fraud related to a 2018 short campaign targeting the company. The indictment alleged that Left and a hedge fund generated over $3.8 million and $1.1 million in profits respectively from the short campaign, while the SEC previously settled with Anson Advisors Inc. and Anson Funds Management LP for $2.25 million in civil monetary penalties. The company is reviewing the public record to determine whether it has recoverable damages for harm to market value, reputational damage, and legal costs incurred.FinancialContent Business PageIGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short CampaignIGC Pharma announced it is evaluating potential civil remedies following a federal jury verdict convicting Andrew Left, founder of Citron Research, of one count of securities fraud scheme and 12 counts of securities fraud related to an alleged October 2018 short-selling campaign targeting the company. The indictment alleged that trading from short campaigns targeting IGC generated over $3.8 million in profits for the hedge fund involved and over $1.1 million for Left, while a separate SEC settlement found Anson Advisors paid a short publisher shares of trading profits from bearish tweets concerning IGC, with combined civil penalties of $2.25 million. IGC's Board of Directors is reviewing the public record to determine whether the company has recoverable damages including harm to market value, reputational harm, and legal costs.NasdaqRegulatory Roundup: Short and Distort: What a Recent Conviction Means for Market SurveillanceAndrew Left, an activist short seller, was convicted by the U.S. Department of Justice in a $21 million securities fraud case for running a "short and distort" scheme in which he publicly promoted stocks through Citron Research while secretly trading in the opposite direction. The case is notable because prosecutors focused not on whether the published views were false, but on the sequencing of position-taking before commentary, market reaction after publication, and rapid reversal of positions to profit from short-term volatility. The conviction could influence how regulators, surveillance teams, and compliance functions assess the relationship between public commentary and trading behavior going forward.BitgetCitron Research founder Andrew Left’s sentencing hearing is scheduled for August 31, 2026, facing a maximum sentence of 265 years.The sentencing hearing for Citron Research founder Andrew Left is scheduled for August 31, 2026, with a theoretical maximum sentence of up to 265 years. Prosecutors allege that Left used short-term options and pre-set limit orders to bet on stock price fluctuations of major companies including NVIDIA, Tesla, Facebook, General Electric, and Luckin Coffee. The extraordinary maximum sentence reflects the cumulative potential penalties across multiple charges related to the alleged scheme.36krShort Seller Fleeced Retail Investors of 140M Yuan in Five Years, Still Shorting Stocks Amid LifeAndrew Left, founder of Citron Research, was found guilty of securities fraud by a federal jury, facing up to 370 years in prison. He is accused of profiting about $20 million from illegal transactions and manipulating stock prices via social media. He continues shorting stocks, including SanDisk, despite the conviction.New York PostAndrew Left faces 20 years in prison — but having a correct opinion about a stock shouldn’t be a crimeAndrew Left, founder of short-selling firm Citron Research, was convicted of 13 counts of securities fraud in a Los Angeles federal court after a two-week trial, facing up to 20 years in prison when sentenced in August. Prosecutors alleged that Left deliberately circulated research on social media and financial television to move stock prices and generate profits, though the article notes his trades often proved accurate in hindsight. The opinion piece argues that while purposely moving stock prices may be legally questionable, having correct opinions about stocks should not constitute a crime, and raises concerns about whether short selling is being treated as de facto illegal.The Motley FoolTurnaround Stories and Shorting StocksDollar General reported earnings that beat expectations and raised guidance, though same-store sales growth lagged inflation. The company is renovating stores, with 1,400 completed in Q1. The podcast also covered Citron Research's Andrew Left's fraud conviction and short-seller business practices.TheStreet.comLouis Navellier warns of biggest mistake investors can make in 2026Louis Navellier warns that the biggest investing mistake in 2026 is staying too bearish, citing Andrew Left's conviction as a setback for short selling. He points to rising manufacturing, durable goods orders, and AI-driven productivity as support for growth stocks. He advises investors to buy dips in fundamentally strong companies.FortuneTop short seller Andrew Lift convicted of securities fraud after getting caught saying ‘taking candy from a baby’Andrew Left, owner of Citron Research, was convicted of securities fraud by a federal grand jury in California. He was charged with engaging in securities fraud schemes and making false statements, with a potential prison sentence of up to 25 years.Business InsiderAndrew Left's Conviction Could Have Chilling Effect, Market Pros SayAndrew Left, founder of short-selling firm Citron Research, was found guilty in a Los Angeles court of 13 counts of securities fraud tied to his social media comments about stocks including Tesla, Nvidia, and Palantir, and his subsequent trading following those statements. The conviction, which could result in years of prison time when sentenced in August, is being viewed by market veterans as a potential turning point for the short-selling industry that could create a chilling effect on activist short-sellers. Industry participants including Iceberg Research and Muddy Waters have reacted by either reaffirming their practices or updating their disclosure protocols, while legal experts hope the ruling prompts clearer compliance standards rather than fewer market challenges.